Notice of Annual Meeting of Shareholders 2025

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN 609 017 969



Notice of Annual Meeting of Shareholders 2025


Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or
the Company) will be held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand,
on Friday, 1 August 2025 commencing at 10.30am (New Zealand time).

Agenda

A Addresses

Our Chairman, David Flacks, and our Founder and Chief Executive Officer, Hartley Atkinson, will
provide an overview of the Company’s performance for the year ended 31 March 2025. There will
also be an opportunity for shareholders to ask questions.

B Resolutions

Shareholders will be asked to consider, and if thought fit, pass the following ordinary resolutions:

1. That the directors are authorised to fix the fees and expenses of Deloitte as
auditor for the 2026 financial year.


2. That Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

3. That Allison Yorston be elected as a director of AFT Pharmaceuticals Limited.


Each resolution is an ordinary resolution and must be approved by a simple majority of the votes of
those shareholders entitled to vote and voting on the resolution.


See explanatory notes on each resolution below. No shareholder is restricted from voting on any
resolution.

The Board recommends unanimously that you vote in favour of all resolutions.

C General Business

To consider any other matter that may be brought properly before the Annual Meeting.


By Order of the AFT Pharmaceuticals Limited Board




David Flacks
Chairman

27 June 2025

Page | 2

Explanatory Notes


Resolution 1: Auditor’s Remuneration
Deloitte is automatically reappointed auditor of
the Company at the Annual Meeting pursuant
to the Companies Act 1993. The resolution
sought is to authorise the directors to fix the
remuneration of the auditor pursuant to section
207(S)(a) of the Companies Act 1993.

Resolution 2: Re-election of Dr Hartley Atkinson
as a Director
Hartley was appointed as an executive director
by the shareholders of AFT on 4 September 1997
and was last re-elected in 2022. In accordance
with the applicable NZX listing rules, Hartley
retires by rotation and, being eligible, offers
himself for re-election as a director of AFT at the
meeting. The Board unanimously supports
Hartley’s re-election and considers Hartley to be
a non-independent director as he is an
executive officer and majority shareholder of
AFT.

Dr Hartley Atkinson
Founder, Executive Director and Chief Executive
Officer
Hartley founded AFT in 1997. Before founding
AFT, Hartley worked at Swiss multinational
pharmaceutical company, Roche, for eight
years where he held positions as Sales &
Marketing Director, Medical Director, Product
Manager and Medical Manager. Prior to his
work at Roche, Hartley was a Drug Information
Pharmacist and Researcher at the Department
of Clinical Pharmacology, Christchurch Hospital.
Hartley holds a Doctorate in Pharmacology, a
Masters in Pharmaceutical Chemistry with
distinction, and a Degree in Pharmacy, all from
the University of Otago.
Hartley is the current Chief Executive Officer
and a majority shareholder of AFT.







Resolution 3: Election of Allison Yorston as a Director
Allison was appointed as a director by the Board on
12 November 2024. In accordance with the
applicable NZX listing rules, Allison retires and, being
eligible, offers herself for election as a director of AFT
at the meeting. The Board unanimously supports
Allison’s election and considers Allison to be an
independent director.
Allison Yorston
Independent Director
Allison brings to AFT more than 20 years of blue-chip
fast-moving consumer goods, telecommunications
and retail marketing experience gained across
Australia and New Zealand at senior management
and C-suite levels. She has managed brand
turnarounds and grown and developed marketing
teams to deliver share gains in competitive markets
and is experienced at managing multi-brand
portfolios including both product and corporate
brands. She is currently Director of Marketing at
Griffins Snacks and is a former Director of the
Australian Beverages Council and a former Chief
Marketing Officer at Suntory Beverage & Food
Oceania. Prior to Suntory she held senior marketing
roles at Vodafone, Fonterra and Sanitarium. Allison is
a Graduate of the Australian Institute of Company
Directors Course and a member of the AICD.

Page | 3

Important Information



Attendance at Meeting
All shareholders registered on the Company’s
share register at 5pm Wednesday 30 July 2025
are entitled to attend and vote at the meeting.
Voting and Proxies
Voting at the meeting shall be by way of a poll
of the Company's shareholders entitled to vote
and voting.
A shareholder entitled to attend and vote at
the meeting can appoint a proxy to attend and
vote on that shareholder’s behalf. A proxy
need not be a shareholder. The Chair of the
meeting may be appointed to act as proxy.
If the Chair of the meeting is appointed to act
as proxy and is not directed how to vote, the
Chair will vote in favour of all the resolutions.
If you do not name a person as your proxy but
otherwise complete the proxy form in full or your
named proxy does not attend the meeting, the
Chairman will act as your proxy and will only
vote in accordance with your express direction.
A shareholder wishing to appoint a proxy can
do so by visiting www.investorvote.co.nz.
Shareholders will be required to enter their
CSN/Holder Number and postcode or country
of residence to complete the online
appointment.
Alternatively, shareholders can appoint a proxy
by completing the enclosed proxy form and
returning it to Computershare Investor Services
Limited by any of the methods specified on the
proxy form.
The proxy form must be received no later than
10.30am on Wednesday 30 July 2025 (being 48
hours prior to the meeting).




Webcast
The Annual Meeting will be webcast live. To view and
listen to the webcast, please visit AFT 2025 Annual
Meeting webcast
- https://webcast.openbriefing.com/afp-agm-2025/
Note that shareholders joining by webcast will not be
able to vote at the meeting or ask questions. In order to
vote you will need to appoint a proxy in accordance
with the above instructions before 10.30am on
Wednesday 30 July 2025.
If you have any questions you would like
considered at the meeting, please send them to
investor.relations@aftpharm.com in advance of
the meeting.
More Information
If you have any questions, or for more
information, please contact AFT’s Company
Secretary, at investor.relations@aftpharm.com